Paper7700528
Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology.
Perry EK and 8 others. Neuroscience, 1995. Cited by 306 papers, by iCite.
Cite this record
ConductScience Library. Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology. Papers, record 7700528. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7700528
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| Dementia | Major topic |
| Parkinson Disease | Major topic |
| Receptors, Nicotinic | Major topic |
| Acetylcholinesterase | |
| Aged | |
| Hippocampus | |
| Humans | |
| Lewy Bodies | |
| Mesencephalon | |
| Middle Aged | |
| Substantia Nigra | |
| Temporal Lobe |
Source PubMed
Cited by71
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 306 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42544822 | Increased Binding of [18F]Nifene, a PET Imaging Probe for α4β2* Nicotinic Acetylcholinergic Receptors in Hippocampus-Subiculum of Postmortem Human Parkinson's Disease Brain. | Synapse | 2026 | https://conductscience.org/library/papers/42544822 | PubMed |
| 40635462 | Proposed mechanisms of neuroprotection for nicotine in Parkinson's disease. | J Parkinsons Dis | 2025 | https://conductscience.org/library/papers/40635462 | PubMed |
| 38566385 | Recent Advances in the Treatment and Management of Alzheimer's Disease: A Precision Medicine Perspective. | Curr Top Med Chem | 2024 | https://conductscience.org/library/papers/38566385 | PubMed |
| 38190053 | Addiction-related brain networks identification via Graph Diffusion Reconstruction Network. | Brain Inform | 2024 | https://conductscience.org/library/papers/38190053 | PubMed |
| 37284149 | Alzheimer's disease is an inherent, natural part of human brain aging: an integrated perspective. | Free Neuropathol | 2022 | https://conductscience.org/library/papers/37284149 | PubMed |
| 36668838 | Neurotoxins Acting at Synaptic Sites: A Brief Review on Mechanisms and Clinical Applications. | Toxins (Basel) | 2022 | https://conductscience.org/library/papers/36668838 | PubMed |
| 35150755 | Biological determinants impact the neurovascular toxicity of nicotine and tobacco smoke: A pharmacokinetic and pharmacodynamics perspective. | Neurotoxicology | 2022 | https://conductscience.org/library/papers/35150755 | PubMed |
| 35130968 | Cholinergic receptor binding in unimpaired older adults, mild cognitive impairment, and Alzheimer's disease dementia. | Alzheimers Res Ther | 2022 | https://conductscience.org/library/papers/35130968 | PubMed |
| 34684720 | Neuroinflammation Modulation via α7 Nicotinic Acetylcholine Receptor and Its Chaperone, RIC-3. | Molecules | 2021 | https://conductscience.org/library/papers/34684720 | PubMed |
| 34301823 | Therapeutic Targeting of α7 Nicotinic Acetylcholine Receptors. | Pharmacol Rev | 2021 | https://conductscience.org/library/papers/34301823 | PubMed |
| 34272732 | Basal forebrain cholinergic system in the dementias: Vulnerability, resilience, and resistance. | J Neurochem | 2021 | https://conductscience.org/library/papers/34272732 | PubMed |
| 33413694 | Loss of cholinergic innervation differentially affects eNOS-mediated blood flow, drainage of Aβ and cerebral amyloid angiopathy in the cortex and hippocampus of adult mice. | Acta Neuropathol Commun | 2021 | https://conductscience.org/library/papers/33413694 | PubMed |
| 32962300 | Signalling Pathways Implicated in Alzheimer's Disease Neurodegeneration in Individuals with and without Down Syndrome. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32962300 | PubMed |
| 32935187 | (+)-[18F]Flubatine as a novel α4β2 nicotinic acetylcholine receptor PET ligand-results of the first-in-human brain imaging application in patients with β-amyloid PET-confirmed Alzheimer's disease and healthy controls. | Eur J Nucl Med Mol Imaging | 2021 | https://conductscience.org/library/papers/32935187 | PubMed |
| 32323319 | Expression profiling of precuneus layer III cathepsin D-immunopositive pyramidal neurons in mild cognitive impairment and Alzheimer's disease: Evidence for neuronal signaling vulnerability. | J Comp Neurol | 2020 | https://conductscience.org/library/papers/32323319 | PubMed |
| 32076403 | Strategies for the Treatment of Parkinson's Disease: Beyond Dopamine. | Front Aging Neurosci | 2020 | https://conductscience.org/library/papers/32076403 | PubMed |
| 31907068 | Changes in gray matter volume and functional connectivity in dementia with Lewy bodies compared to Alzheimer's disease and normal aging: implications for fluctuations. | Alzheimers Res Ther | 2020 | https://conductscience.org/library/papers/31907068 | PubMed |
| 31659510 | Current radiotracers to image neurodegenerative diseases. | EJNMMI Radiopharm Chem | 2019 | https://conductscience.org/library/papers/31659510 | PubMed |
| 31307115 | Hallucinations, somatic-functional disorders of PD-DLB as expressions of thalamic dysfunction. | Mov Disord | 2019 | https://conductscience.org/library/papers/31307115 | PubMed |
| 30777653 | Genetic variants in nicotinic receptors and smoking cessation in Parkinson's disease. | Parkinsonism Relat Disord | 2019 | https://conductscience.org/library/papers/30777653 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7700528
GET https://conductscience.org/api/papers/v1/7700528/cited_by?page=2